| 2026-08-21 | Press release | Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch |
| 2026-08-17 | Press release | Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules |
| 2026-08-11 | Press release | Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026 |
| 2026-08-05 | Press release | Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment |
| 2026-05-13 | Press release | Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026 |
| 2026-05-13 | Press release | PDF |
| 2026-04-02 | Press release | Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with it |
| 2026-03-26 | Press release | Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 |
| 2026-03-26 | Press release | PDF |
| 2026-03-10 | Press release | Mar 10, 2026 • 8:30am EDT Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing |
| 2026-03-05 | Press release | Dermata Opens a New Chapter with the Release of Tome Skincare |
| 2026-01-20 | Press release | Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office |
| 2025-11-14 | Press release | PDF |
| 2025-08-13 | Press release | PDF |
| 2025-05-14 | Press release | PDF |
| 2025-03-17 | Press release | PDF |
| 2025-01-29 | Press release | Dermata to Present on BioPub on January 31, 2025 |
| 2024-11-13 | Press release | PDF |
| 2024-11-13 | Press release | Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results |
| 2024-10-08 | Press release | Dermata Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit on Tuesday, October 15, 2024 |
| 2024-09-05 | Press release | Dermata Therapeutics Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9 |
| 2024-08-07 | Press release | PDF |
| 2024-08-07 | Press release | Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results |
| 2024-05-15 | Press release | PDF |
| 2024-05-15 | Press release | Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results |
| 2024-03-21 | Press release | PDF |
| 2024-03-21 | Press release | Dermata Therapeutics Provides Corporate Update and Reports Full Year 2023 Financial Results |
| 2023-11-09 | Press release | PDF |
| 2023-11-09 | Press release | Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results |
| 2023-08-10 | Press release | PDF |
| 2023-08-10 | Press release | Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results |
| 2023-05-11 | Press release | PDF |
| 2023-02-21 | Press release | PDF |
| 2023-02-21 | Press release | Dermata Therapeutics Provides Corporate Update and Reports Full Year 2022 Financial Results |
| 2022-11-10 | Press release | PDF |
| 2022-11-10 | Press release | Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results |
| 2022-08-15 | Press release | PDF |
| 2022-08-15 | Press release | Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results |
| 2022-05-16 | Press release | PDF |
| 2022-05-16 | Press release | Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results |